RSS

UNVC Univec Conglomerate Inc

Last Post: 9:59 AM
Followers: 228
Posts Today: 0
Views Today: 21148

UNVC Stock Quote & Tools

$0.0018 ▲ +0.0000 (+0.00%) As of Oct 27, 2:41 PM EDT
Last0.0018
$ Chg0.0000
Open—
High—
Beta0.8504
Year High0.005
Market Cap4.54M
P/B Ratio—
EPS—
Avg Vol (30d)316.2K
Volume0
% Chg+0.00%
Prev Close0.0018
Low—
VWAP0.00178
Year Low0.001
Total Shares2.52B
Shares Out2.52B
Float2.52B
ExchangeOTCID
Healthcare Healthcare Providers & Services

UNVC Stock Message Board Discussion

  1. armyseal
  2. 12Retyr
  3. mikeyt1818
  4. armyseal

Top 10 Most Recent News Articles

UP Fintech Faces Class Action Over Alleged Misconduct

Updated Category News Views 51

UP Fintech: A Financial Storm Brews When it rains, it sure pours. Investors are finding themselves stuck in the middle of a squall as UP Fintech Holding Limited's legal troubles unfold. Robbins LLP, a shareholder rights law firm, has filed a class-action lawsuit targeting UP Fintech (NASDAQ:TIGR), and the lawsuit isn't just some casual fling—it digs deep into the...

Continue Reading
Ukraine's Satellite: A New Era of Sovereignty

Updated Category News Views 145

Ukraine's Bold Satellite Leap Alright, folks! Ukraine’s got a satellite cruising in orbit, and let me tell you, this ain't just some vanity space flight—it’s a downright pivotal shift in their communications game. Been a rough road to this milestone, but now we're seeing them break free from relying on foreign infrastructure for their satellite needs. What this...

Continue Reading
Ozelle's O-Cyte 1: Revolutionizing Hematology with AI

Updated Category News Views 36

O-Cyte 1 Leads the Charge at MEDICA 2026 With all the chatter floating around the latest whiz-bang healthcare technology, it's downright refreshing to stumble upon something as genuinely promising as Ozelle's O-Cyte 1. Slated to be the talk of the town at this year’s MEDICA in DÜSSELDORF, this shiny new automated hematology analyzer promises to marry the best of AI and...

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 147

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Endava Faces Class Action: Investors Eye Their Next Move

Updated Category News Views 52

A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...

Continue Reading
KROMATID Joins CIRM's Genomic Analysis Initiative

Updated Category News Views 58

New Partnership Opens Doors for Genomic Mastery In a world where biotechnology races to meet the needs of modern medicine, KROMATID's recent nod as an Industry Resource Partnership (IRP) member, courtesy of the California Institute for Regenerative Medicine (CIRM), makes some noise worth noting. This membership isn't just a feather in their cap—it's their ticket to...

Continue Reading
Ecopetrol Sets Q3 2026 Results Release, Conference Call

Updated Category News Views 110

Big Day Incoming: Ecopetrol's Q3 Results Alright, folks, buckle up because Ecopetrol is about to drop its third-quarter numbers for 2026. On November 10th, after the bell, Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) will lift the veil on its financial and operational performance. Make sure you got your calendars marked, and better yet, your browser's up to date. Nothing's...

Continue Reading
DERMALOG Bolsters Biometric Defense with Key Wins

Updated Category News Views 19

DERMALOG Rides High with PAD Success Germany-based DERMALOG just gave biometric crooks a run for their money. In a testament to gutsy tech work, they've hit a homerun with the latest independent security evaluations. They’ve managed to spot and shut down all 1,500 tried and tested spoofs in presentation attacks—think photos, videos, and phony fingerprints. That’s no...

Continue Reading
Enertech's New Moves Aim to Make Geothermal Mainstream

Updated Category News Views 0

Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...

Continue Reading
BlueNord Signals Strategic Shift with Vår Energi Merger

Updated Category News Views 18

BlueNord's Bold Move in the Energy Sector With the ink barely dry on their third-quarter results, BlueNord has dropped a bombshell: a merger approved with Vår Energi. This isn't just another page in their corporate books—it's a strategic pivot that could redefine their place within the oil and gas arena. Anybody keeping an eye on the energy sector right now should sit...

Continue Reading

Top 5 Most Recently Viewed Articles

Enovis Corporation's Steady Growth in Second Quarter Results

Updated Category News Views 141

Enovis Corporation Reports Strong Second Quarter Performance Enovis Corporation (NYSE: ENOV), a leader in innovative medical technologies, has recently unveiled its second quarter financial results, showcasing impressive operational effectiveness and growth across key business segments. Sales Growth and Financial Highlights The company achieved a remarkable 7% increase in...

Continue Reading
Rani Therapeutics Secures $10M in Direct Offering Funds

Updated Category News Views 72

Rani Therapeutics Secures $10 Million through Direct Offering Rani Therapeutics Holdings, Inc. (Nasdaq: RANI) recently announced a significant step in its financial strategy by entering a securities purchase agreement with a prominent institutional investor. This agreement involves the purchase and sale of 3,000,000 shares of Rani Therapeutics’ Class A common stock,...

Continue Reading
Vantage Markets Triumphs as Most Trusted Broker at Summit

Updated Category News Views 327

Vantage Markets Triumphs as Most Trusted Broker at Summit Vantage Markets is proud to announce its recognition as the 'Most Trusted Broker' at the Smart Vision Summit 2025, a significant event that brought together traders, investors, and key industry figures. This summit was an important platform for Vantage to reinforce its commitment to excellence in financial trading,...

Continue Reading
Olema Pharmaceuticals, Inc. Unveils Promising Preclinical Data

Updated Category News Views 56

Olema Pharmaceuticals, Inc. to Present Innovative Findings Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), known for its commitment to women's cancer therapies, is set to unveil groundbreaking preclinical combination data. This will be showcased at the prestigious EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. The...

Continue Reading
Minute Media's Strategic Move: Acquiring VideoVerse's AI Technology

Updated Category News Views 310

Minute Media's Bold Acquisition of VideoVerse Media startup Minute Media has made headlines with its major acquisition of VideoVerse, an Indian AI startup valued between $200 million and $250 million. This strategic investment aims to enhance Minute Media's capability to transform sports content, making it more dynamic and engaging for fans. Capitalizing on Emerging...

Continue Reading